Skip to main content

Advertisement

Log in

Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

We investigated whether disturbance of glycocalyx integrity is related with increased cardiovascular risk. In 600 healthy subjects, we measured perfused boundary region (PBR), a marker of glycocalyx integrity, in sublingual microvessels with diameter ranging 5–25 µm using a dedicated camera (Sideview Darkfield Imaging). Increased PBR indicates reduced glycocalyx thickness. We prospectively monitored the occurrence of cardiovascular events (MACE-death, myocardial infarction, and stroke) during a 6-year follow-up. Fifty-seven MACE were documented. Increased values of PBR5-25 predicted higher risk for MACE in a model including sex, age, hyperlipidemia, diabetes, hypertension, smoking, family history of coronary disease, treatment with ACEi/ARBs, or lipid-lowering agents (hazard ratio (HR), 6.44, p = 0.011; net reclassification improvement (NRI), 28%; C-statistic: 0.761). PBR5-25 was an independent and additive predictor of outcome when added in a model including the European Heart SCORE, diabetes, family history of CAD, and medication (HR, 4.71; NRI: 39.7%, C-statistic from 0.653 to 0.693; p < 0.01).Glycocalyx integrity is an independent and additive predictor to risk factors for MACE at 6-year follow-up in individuals without cardiovascular disease. ClinicalTrials.govIdentifier:NCT04646252.

Graphical abstract

PBR5-25 was an independent and additive predictor of adverse cardiovascular events in a model including the European Heart SCORE, diabetes, family history of coronary disease, and medication (HR: 4.71, NRI: 39.7%, C-statistic from 0.653 to 0.693; p < 0.01, NRI:37.9%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

The datasets generated and/or analyzed during the current study are not publicly available due to information that could compromise the privacy of research participants but are available from the corresponding author on reasonable request.

Code Availability

Not applicable.

Abbreviations

ACEi/ARBs:

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers

AMI:

Acute myocardial infarction

CAD:

Coronary artery disease

DM:

Diabetes mellitus

GLS:

Global longitudinal strain

HF:

Heart failure

HR:

Hazard ratio

MACE:

Major adverse cardiovascular events

NO:

Nitric oxide

NRI:

Net reclassification improvement

PAD:

Peripheral arterial disease

PBR:

Perfused boundary region

RBC:

Red blood cell

SDF:

Sideview Darkfield

TGs:

Triglycerides

References

  1. Kapuku, G. K., Harshfield, G. A., Davis, H. C., & Treiber, F. A. (2006). Early markers of cardiovascular disease. Vascular Pharmacology, 45, 277–280.

    Article  CAS  PubMed  Google Scholar 

  2. Deanfield, J. E., & Halcox, J. P. (2007). Rabelink TJ Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 115, 1285–1295.

    Article  PubMed  Google Scholar 

  3. Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A., & oudeEgbrink, M. G. (2007). The endothelial glycocalyx: composition, functions, and visualization. Pflugers Archiv, 454, 345–359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pries, A. R., Secomb, T. W., & Gaehtgens, P. (2005). The endothelial surface layer. Pflugers Archiv. European Journal of Physiology, 440, 653–666.

    Article  Google Scholar 

  5. Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007). The structure and function of the endothelial glycocalyx layer. Annual Review of Biomedical Engineering, 9, 121–167.

    Article  CAS  PubMed  Google Scholar 

  6. Levick, J. R. (2004). Revision of the Starling principle: New views of tissue fluid balance. Journal of Physiology, 557, 704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Levick, J. R., & Michel, C. C. (2010). Microvascular fluid exchange and the revised Starling principle. Cardiovascular Research, 87, 198–210.

    Article  CAS  PubMed  Google Scholar 

  8. Tarbell, J. M. (2003). Mass transport in arteries and the localization of atherosclerosis. Annual Review of Biomedical Engineering, 5, 79–118.

    Article  CAS  PubMed  Google Scholar 

  9. Weinbaum, S., Zhang, X., Han, Y., Vink, H., & Cowin, S. C. (2003). Mechanotransduction and flow across the endothelial glycocalyx. Proceedings of the National Academy of Sciences of the United States of America, 100, 7988–7995.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Schmidt, E. P., Yang, Y., Janssen, W. J., Gandjeva, A., Perez, M. J., et al. (2012). The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nature Medicine, 18, 1217.

    Article  CAS  PubMed  Google Scholar 

  11. Vink, H., Constantinescu, A. A., & Spaan, J. A. (2000). Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet endothelial cell adhesion. Circulation, 101, 1500–1502.

    Article  CAS  PubMed  Google Scholar 

  12. Nieuwdorp, M., Meuwese, M. C., Vink, H., Hoekstra, J. B., Kastelein, J. J., & Stroes, E. S. (2005). The endothelial glycocalyx: A potential barrier between health and vascular disease. Current Opinion in Lipidology, 16, 507–511.

    Article  CAS  PubMed  Google Scholar 

  13. Nieuwdorp, M., Meuwese, M. C., Mooij, H. L., Ince, C., Broekhuizen, L. N., Kastelein, J. J., Troes, E. S., & Vink, H. (2008). Measuring endothelial glycocalyx dimensions in humans: A potential novel tool to monitor vascular vulnerability. Journal of Applied Physiology, 104, 845–852.

    Article  PubMed  Google Scholar 

  14. Goedhart, P. T., Khalilzada, M., Bezemer, R., & Merza, J. (2007). Ince C SidestreamDark Field (SDF) imaging: A novel stroboscopic LED ring-based imagingmodality for clinical assessment of the microcirculation. Optics Express, 15, 15101–15114.

    Article  CAS  PubMed  Google Scholar 

  15. Ikonomidis, I., Pavlidis, G., Lambadiari, V., Kousathana, F., Varoudi, M., Spanoudi, F., Maratou, E., Parissis, J., Triantafyllidi, H., & DimitriadisGLekakis, J. (2017). Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage. International Journal of Cardiology, 233, 105–112.

    Article  PubMed  Google Scholar 

  16. Lekakis, J., Abraham, P., Balbarini, A., Blann, A., Boulanger, C. M., Cockcroft, J., Cosentino, F., Deanfield, J., Gallino, A., Ikonomidis, I., Kremastinos, D., Landmesser, U., Protogerou, A., Stefanadis, C., Tousoulis, D., Vassalli, G., Vink, H., Werner, N., Wilkinson, I., & Vlachopoulos, C. (2011). Methods for evaluating endothelial function: A position statement from the European society of Cardiology Working Group on peripheral circulation. European Journal of Cardiovascular Prevention and Rehabilitation, 18, 775–789.

    Article  PubMed  Google Scholar 

  17. Mulders, T. A., Nieuwdorp, M., Stroes, E. S., Vink, H., & Pinto-Sietsma, S. J. (2013). Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease. International Journal of Cardiology, 168, 5026–5028.

    Article  PubMed  Google Scholar 

  18. Amraoui, F., OldeEngberink, R. H., van Gorp, J., Ramdani, A., Vogt, L., & van den Born, B. J. (2014). Microvascular glycocalyx dimension estimated by automated SDF imaging is not related to cardiovascular disease. Microcirculation, 21, 499–505.

    Article  CAS  PubMed  Google Scholar 

  19. Ikonomidis, I., Marinou, M., Vlastos, D., Kourea, K., Andreadou, I., Liarakos, N., Triantafyllidi, H., Pavlidis, G., Tsougos, E., & Parissis, J. (2017). Lekakis J Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Atherosclerosis, 262, 123–130.

    Article  CAS  PubMed  Google Scholar 

  20. Valerio, L., Peters, R. J., Zwinderman, A. H., & Pinto-Sietsma, S. J. (2019). Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study. PLoS One, 14, e0213097.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ikonomidis, I., Voumvourakis, A., Makavos, G., Triantafyllidi, H., Pavlidis, G., Katogiannis, K., et al. (2018). Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives. Journal of Clinical Hypertension (Greenwich), 20, 672–679.

    Article  CAS  Google Scholar 

  22. Lambadiari, V., Pavlidis, G., Kousathana, F., Maratou, E., Georgiou, D., Andreadou, I., Kountouri, A., Varoudi, M., Balampanis, K., Parissis, J., et al. (2019). Effects of different antidiabetic medications on endothelial glycocalyx, myocardial function, and vascular function in type 2 diabetic patients: One year follow-up study. Journal of Clinical Medicine, 8, 983.

    Article  CAS  PubMed Central  Google Scholar 

  23. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 31, 1281–1357.

    Article  CAS  PubMed  Google Scholar 

  24. ADVANCE Collaborative Group, Patel, A., MacMahon, S., Chalmers, J., Neal, B., & Billot, L. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine., 2008(358), 2560–2572.

    Google Scholar 

  25. Reiner, Z., Catapano, A. L., et al. (2011). ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 32, 1769–1818.

    Article  PubMed  Google Scholar 

  26. Mannan, H., Stevenson, C., Peeters, A., Walls, H., & McNeil, J. (2010). Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart International, 5, e11.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sivapalaratnam, S., Boekholdt, S. M., Trip, M. D., Sandhu, M. S., Luben, R., Kastelein, J. J., Wareham, N. J., & Khaw, K. T. (2010). Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart, 96, 1985–1989.

    Article  PubMed  Google Scholar 

  28. Conroy, R., Pyorala, K., Fitzgerald, A. P., Sans, S., Menotti, A., De Backer, G., De Bacquer, D., Ducimetie’re, P., Jousilahti, P., Keil, U., Njølstad, I., Oganov, R. G., Thomsen, T., Tunstall-Pedoe, H., Tverdal, A., Wedel, H., Whincup, P., Wilhelmsen, L., & Graham, I. (2003). Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal, 24, 987–1003.

    Article  CAS  PubMed  Google Scholar 

  29. Stronks, K., Kulu-Glasgow, I., & Agyemang, C. (2009). The utility of ’country of birth’ for the classification of ethnic groups in health research: The Dutch experience. Ethnicity & Health, 14, 255–269.

    Article  Google Scholar 

  30. Lee DH, Dane MJC, van den Berg B.M., Boels M.G.S., van Teeffelen J. W., de Mutsert R., den Heijer M., Rosendaal F.R., van der Vlag J., Jan van Zonneveld A., Vink H., Rabelink T.J. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One. 2014; 9:e96477.

  31. Ikonomidis, I., Frogoudaki, A., Vrettou, A. R., Andreou, I., Palaiodimou, L., Katogiannis, K., Liantinioti, C., Vlastos, D., Zervas, P., Varoudi, M., Lambadiari, V., Triantafyllidi, H., Pavlidis, G., Efentakis, P., Tsoumani, M., Tsantes, A. E., Parissis, J., Revela, I., Andreadou, I., & Tsivgoulis, G. (2019). Impaired arterial elastic. Properties and endothelial glycocalyx in patients with embolic stroke of undetermined source. Thrombosis and Haemostasis, 119, 1860–1868.

    Article  PubMed  Google Scholar 

  32. Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, I., Stefanadis, C., & ATTICA Study. (2008). Five-year incidence of cardiovascular disease and its predictors in Greece: The ATTICA study. Vascular Medicine, 13, 113–121. .

  33. Lachin, J. M., & Foulkes, M. A. (1986). Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics, 42, 507–519.

    Article  CAS  PubMed  Google Scholar 

  34. Hintze, J. (2011). PASS 11. NCSS, LLC. Kaysville, Utah, USA. www.ncss.com.

  35. Nieuwdorp, M., van Haeften, T. W., Gouverneur, M. C., Mooij, H. L., van Lieshout, M. H., Levi, M., Meijers, J. C., Holleman, F., Hoekstra, J. B., Vink, H., et al. (2006). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes, 55, 480–486.

    Article  CAS  PubMed  Google Scholar 

  36. Zuurbier, C. J., Demirci, C., Koeman, A., Vink, H., & Ince, C. (2005). Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. J ApplPhysiol, 99, 1471–1476.

    Google Scholar 

  37. Machin, D. R., Gates, P. E., Vink, H., Frech, T. M., & Donato, A. J. (2017). Automated measurement of microvascular function reveals dysfunction in systemic sclerosis: A cross-sectional study. Journal of Rheumatology, 44, 1603–1611.

    Article  CAS  PubMed  Google Scholar 

  38. Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., Katogiannis, K., Dimitriadis, G., Bamias, A., Iliodromitis, E., & Lambadiari, V. (2020). Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment. Journal of the American Heart Association, 9, e015716.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kaufmann, D., Szwoch, M., Kwiatkowska, J., Raczak, G., & Daniłowicz-Szymanowicz, L. (2019). Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction. PLoS One, 14, e0225829.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Dekker, N. A. M., Veerhoek, D., Koning, N. J., van Leeuwen, A. L. I., Elbers, P. W. G., van den Brom, C. E., Vonk, A. B. A., & Boer, C. (2019). Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass. Anaesthesia, 74, 609–618.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Koning, N. J., Vonk, A. B., Vink, H., & Boer, C. (2016). Side-by-Side alterations in glycocalyx thickness and perfused microvascular density during acute microcirculatory alterations in cardiac surgery. Microcirculation, 23, 69–74.

    Article  PubMed  Google Scholar 

  42. Nussbaum, C., Haberer, A., Tiefenthaller, A., et al. (2015). Pertubation of the microvascular glycocalyx and perfusion in infants after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 150, 1474–1481.

    Article  PubMed  Google Scholar 

  43. Ikonomidis, I., Vlastos, D., Andreadou, I., Gazouli, M., Efentakis, P., Varoudi, M., Makavos, G., Kapelouzou, A., Lekakis, J., Parissis, J., Katsanos, S., Tsilivarakis, D., Hausenloy, D. J., Alexopoulos, D., Cokkinos, D. V., Bøtker, H. E., & Iliodromitis, E. K. (2021). Vascular conditioning prevents adverse left ventricular remodeling after acute myocardial infarction: A randomised remote conditioning study. Basic Research in Cardiology, 116, 9.

    Article  CAS  PubMed  Google Scholar 

  44. Wadowski, P. P., Hülsmann, M., Schörgenhofer, C., Lang, I. M., Wurm, R., Gremmel, T., Koppensteiner, R., Steinlechner, B., Schwameis, M., & Jilma, B. (2018). Sublingual functional capillary rarefaction in chronic heart failure. European Journal of Clinical Investigation, 48, e12869.

    Article  Google Scholar 

  45. Gorshkov, A. Y., Klimushina, M. V., Boytsov, S. A., Kots, A. Y., & Gumanova, N. G. (2018). Increase in perfused boundary region of endothelial glycocalyx is associated with higher prevalence of ischemic heart disease and lesions of microcirculation and vascular wall. Microcirculation, 25, e12454.

    Article  PubMed  Google Scholar 

  46. Martens, R. J. H., Vink, H., van Oostenbrugge, R. J., & Staals, J. (2013). Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovascular Diseases, 35, 451–454.

    Article  CAS  PubMed  Google Scholar 

  47. Rovas, A., Osiaevi, I., Buscher, K., Sackarnd, J., Tepasse, P. R., Fobker, M., Kühn, J., Braune, S., Göbel, U., Thölking, G., Gröschel, A., Pavenstädt, H., Vink, H., & Kümpers, P. (2021). Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis, 24, 145–157.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Authors contributions is as follows: (1) study conception and design (Ignatios Ikonomidis, John Thymis, Vaia Lambadiari); (2) laboratory measurements (Foteini Kousathana, Charilaos Triantafyllou, Gavriella Kostelli, Dimitrios Vlastos, Aikaterini Kountouri, Eftihia Polyzogopoulou); (3) data analysis and interpretation (Georgia-Angeliki Koliou, Panagiotis Simitsis, George Pavlidis, Konstantinos Katogiannis, Helen Triantafyllidi, Spiridon Katsanos); and (4) drafting of the manuscript (John Lekakis, John Parissis, Gerasimos Filippatos, Evangelia Papadavid). All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ignatios Ikonomidis.

Ethics declarations

Ethics Approval

The study was conducted according to the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of Attikon University Hospital.

Consent to Participate

All participants signed an informed consent.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Associate Editor Marat Fudim oversaw the review of this article.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ikonomidis, I., Thymis, J., Simitsis, P. et al. Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study. J. of Cardiovasc. Trans. Res. 15, 890–902 (2022). https://doi.org/10.1007/s12265-021-10180-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-021-10180-2

Keywords

Navigation